# Central Bancompany, Inc.: financial statements, quarterly

CBC · Nasdaq · CIK 2065601 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbc.md) · [Financials](/companies/cbc/financials.md) · [Filings](/companies/cbc/filings.md) · [Insiders](/companies/cbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbc/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Income tax | $m | [28.1](/filings/0001628280-26-035492.md) | [27.0](/filings/0001628280-26-057081.md) | [32.9](/filings/0001628280-26-035492.md) | [33.7](/filings/0001628280-26-057081.md) |
| Net income | $m | [94.8](/filings/0001628280-26-035492.md) | [91.4](/filings/0001628280-26-057081.md) | [111](/filings/0001628280-26-035492.md) | [114](/filings/0001628280-26-057081.md) |
| Diluted EPS | $ per share | [0.43](/filings/0001628280-26-035492.md) | [0.41](/filings/0001628280-26-057081.md) | [0.46](/filings/0001628280-26-035492.md) | [0.47](/filings/0001628280-26-057081.md) |
| Basic EPS | $ per share | [0.43](/filings/0001628280-26-035492.md) | [0.41](/filings/0001628280-26-057081.md) | [0.46](/filings/0001628280-26-035492.md) | [0.48](/filings/0001628280-26-057081.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | not reported | [19.2](/filings/0001628280-26-021067.md) | not reported | not reported | [20.8](/filings/0001628280-26-057081.md) | [20.5](/filings/0001628280-26-035492.md) | [20.3](/filings/0001628280-26-057081.md) |
| Total liabilities | $bn | not reported | [16.1](/filings/0001628280-26-021067.md) | not reported | not reported | [17.0](/filings/0001628280-26-057081.md) | [16.7](/filings/0001628280-26-035492.md) | [16.4](/filings/0001628280-26-057081.md) |
| Shareholders' equity | $bn | [2.7](/filings/0001628280-26-021067.md) | [3.1](/filings/0001628280-26-057081.md) | [3.2](/filings/0001628280-26-057081.md) | [3.2](/filings/0001628280-26-057081.md) | [3.8](/filings/0001628280-26-057081.md) | [3.8](/filings/0001628280-26-057081.md) | [3.9](/filings/0001628280-26-057081.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [102](/filings/0001628280-26-035492.md) | [(43.8) d](/filings/0001628280-26-057081.md) | [210](/filings/0001628280-26-035492.md) | [102 d](/filings/0001628280-26-057081.md) |
| Capital expenditure | $m | [1.3](/filings/0001628280-26-035492.md) | [6.1 d](/filings/0001628280-26-057081.md) | [8.4](/filings/0001628280-26-035492.md) | [5.9 d](/filings/0001628280-26-057081.md) |
| Dividends paid | $m | [12.1](/filings/0001628280-26-035492.md) | [188 d](/filings/0001628280-26-057081.md) | [29.1](/filings/0001628280-26-035492.md) | [28.7 d](/filings/0001628280-26-057081.md) |
| Share repurchases | $m | [0.0](/filings/0001628280-26-035492.md) | [0.0 d](/filings/0001628280-26-057081.md) | [31.1](/filings/0001628280-26-035492.md) | [7.6 d](/filings/0001628280-26-057081.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [220](/filings/0001628280-26-035492.md) | [220](/filings/0001628280-26-057081.md) | [241](/filings/0001628280-26-035492.md) | [240](/filings/0001628280-26-057081.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 239,505,133 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001628280-26-057081.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.